Synthesis of â(1 f 4)-Polysaccharides
J. Am. Chem. Soc., Vol. 122, No. 23, 2000 5435
filtered on C18 Cartridge Sep-Pak Plus (Waters) and then freeze-dried.
The expected tetrasaccharide 121b was obtained in quantitative yield
(59 mg): [R]25D -1 (c 0.32, H2O); 13C NMR (D2O, 75 MHz) δ 103.9,
103.7, 103.1 (2C) (C-1I, II, III, IV), 79.4, 79.1, 79.0 (C-4I, II, III), 76.2, 75.6,
75.1, 74.9, 74.8, 73.7, 73.3, 71.7 (C-2I, II, III, IV, C-3I, II, III, IV, C-5I, II, III,
IV), 69.3 (C-4IV), 61.8-60.8 (C-6I, II, III, IV), 58.0 (OCH3); FABMS: m/z
703 [M + Na]+.
Methyl â-D-Galactopyranosyl-(1f4)-â-D-glucopyranosyl-(1f4)-
â-D-glucopyranosyl -(1f4)-6-bromo-6-deoxy-â-D-glucopyranoside
(13). Lactosyl fluoride 1 (9.0 mg, 0.026 mmol) and methyl 6-bromo-
6-deoxy-â-cellobioside 6 (11.0 mg, 1 equiv) in phosphate buffer (0.1M,
pH 7.0, 1 mL) were incubated with Cel7B Glu197Ala (0.6 mg) at 40
°C. After 7 h, the solution was filtered on C18 Cartridge Sep-Pak Plus
(Waters) and then freeze-dried. The expected tetrasaccharide 13 was
2,3,4-Tri-O-acetyl-6-bromo-6-deoxy-â-D-glucopyranosyl-(1f4)-
1,2,3,6-tetra-O-acetyl-â-D-glucopyranose (19). A catalytic amount of
triethylsilyl triflate (20 µL) was added, dropwise via a syringe, to a
solution of compound 18b (1.5 g, 2.5 mmol) in acetic anhydride (20
mL) cooled at 0 °C. The mixture was stirred at 0 °C for 30 min, and
then saturated aqueous NaHCO3 was added to quench the reaction,
and the products were extracted with CH2Cl2. The organic layers were
dried, concentrated and coevaporated with toluene. HBr (30% w/v in
AcOH, 5 mL) was added to the crude anomeric mixture in CH2Cl2 (10
mL) at 0 °C. After stirring at 0 °C for 30 min and then at room
temperature for an additional 1 h, the reaction mixture was diluted with
CH2Cl2, washed with ice-cold H2O and ice-cold saturated aqueous
NaHCO3 (3×), dried, and concentrated. The resulting bromide and
AgOAc (840 mg, 2 equiv) in a mixture of Ac2O-AcOH (20 mL, 1:1
v/v) were stirred in the dark overnight at room temperature. The mixture
was diluted with CH2Cl2 and filtered through a Celite bed, and the
filtrate was washed with saturated aqueous NaHCO3 (3×), dried, and
concentrated. Filtration through silica gel (EtOAc-petroleum ether 7:3
v/v) gave compound 19 (1.53 g, 88% three steps) which was crystallized
in EtOH, mp 156 °C, [R]25D -2.5 (c 0.81, CHCl3); 13C NMR (CDCl3,
75 MHz) δ 169.3-166.2 (CO), 99.8 (C-1II), 91.5 (C-1I), 75.2 (C-4I),
73.4, 73.3, 72.5, 71.9, 71.4, 70.5, 70.4 (C-2I, II, C-3I, II, C-5I, II, C-4II),
61.5 (C-6I), 30.2 (C-6II), 20.9-20.3 (CH3); 1Η ΝΜR (CDCl3, 300 MHz)
obtained in quantitative yield (19.3 mg): [R]25D +3 (c 0.93, H2O); 13
C
NMR (D2O, 75 MHz) δ 103.9, 103.7, 103.2, 103.1 (C-1I, II, III, IV), 80.9
(C-4I), 79.0, 78.97 (C-4II, III), 76.2, 75.6, 74.9, 74.8, 74.7, 73.76, 73.66,
73.6, 73.3, 71.8 (C-2I, II, III, IV, C-3I, II, III, IV, C-5I, II, III, IV), 69.4 (C-4IV),
III,
61.8, 60.8, 60.7 (C-6II,
IV), 58.2 (OCH3), 33.2 (C-6I); ΗRFABMS
calcd for C25H43BrO20 (M + Na)+ 765.1429, found 765.1435.
2-Acetamido-1,3,6-tri-O-acetyl-2-deoxy-(2,3,4,6-tetra-O-acetyl-â-
D-galactopyranosyl)-(1f4)-(2,3,6-tri-O-acetyl-â-D-glucopyranosyl)-
(1f4)-(2-acetamido-3,6-di-O-acetyl-2-deoxy-â-D-glucopyranosyl)-
(1f4)-r,â-D-glucopyranose (14). Lactosyl fluoride 1 (10.0 mg, 0.029
mmol) and N-acetyl-chitobiose 7 (11.1 mg, 1 equiv) in ammonium
carbonate solution (0.1M, pH 8.0, 1 mL) were incubated with Cel7B
Glu197Ala (0.6 mg) at 40 °C for 24 h. Then the solution was
evaporated, dried in vacuo over sodium pentoxide at 40 °C for 24 h,
acetylated as described for compound 9 and purified by flash column
chromatography using a mixture CH2Cl2-MeOH (95:5 v/v) as eluent.
The tetrasaccharide 14 was obtained in 65% yield (23.6 mg): 13C NMR
(CDCl3, 75 MHz) δ 170.0-169.0 (CO), 101.8, 101.0, 101.3 (C-1II, III,
IV), 92.3, 90.3 (C-1I R,â), 77.1, 75.9, 75.7, 72.7, 71.8, 70.8, 70.6, 69.0,
66.5, 62.2, 62.0, 61.4, 60.6, 53.7, 51.5, 51.0 (C-2I, II, III, IV to C-5 I, II, III,
IV), 20.8-20.5 (CH3); ΗRFABMS calcd for C52H72O33N2 (M + Na)+
1275.3915, found 1275.3914.
δ 5.57 (d, 1H, J1, ) 8.2 Hz, H-1I), 5.20-4.78 (m, 5H, H-2I, H-2II,
2
H-3I, H-3II, H-4II), 4.47 (d, 1H, J1, ) 8 Hz, H-1II), 4.39 (dd, 1H, J5,
2
6 ) 1.6 Hz, Ja, b ) 12.2 Hz, H-6Ia), 4.02 (dd, 1H, J5, 6 ) 4.6 Hz, H-6Ib),
3.80 (t, 1H, J2, 3 ) J3, 4 ) 9 Hz, H-4I), 3.62-3.56 (m, 2H, H-5I, H-5II),
3.40 (dd, 1H, J5, 6 ) 2.6 Hz, Ja, b ) 11.5 Hz, H-6IIa), 3.25 (dd, 1H, J5,
6 ) 7 Hz, H-6IIb), 2.10-1.95 (m, 21H, CH3); DCIMS: m/z 718 [M +
H + NH3]+, 641 [M - OAc]; Anal. Calcd for C26H35BrO17: C,44.65;
H,5.04; Br, 11.42. Found: C, 44.64; H, 5.13; Br,. 11.07.
2,3,4-Tri-O-acetyl-6-bromo-6-deoxy-â-D-glucopyranosyl-(1f4)-
2,3,6-tri-O-acetyl-r-D-glucopyranosyl fluoride (20). A solution of
compound 19 (1.4 g, 2.0 mmol) in HF-pyridine (10 mL, 7:3 v/v) was
stirred at 0 °C for 1.5 h in a plastic vial. The mixture was diluted with
CH2Cl2 and poured into ice-cold aqueous NH3 (3 M); the organic layer
was washed with saturated aqueous NaHCO3 (3×), dried, and
concentrated. Crystallization from EtOH- Et2O gave pure 20 (1.2 g,
90%): mp 177-178 °C; [R]25D +40 (c 1.1, CHCl3); 13C NMR (CDCl3,
Benzyl â-D-Galactopyranosyl-(1f4)-â-D-glucopyranosyl-(1f4)-
â-D-glucopyranosyl-(1f3)-â-D-glucopyranoside (15). Lactosyl fluo-
ride 1 (12.0 mg, 0.035 mmol) and benzyl laminaribioside 8 (15.0 mg,
1 equiv) in phosphate buffer (0.1M, pH 7.0, 1 mL) were incubated
with Cel7B Glu197Ala (0.6 mg) at 40 °C. After 6 h, the solution was
filtered on C18 Cartridge Sep-Pak Plus (Waters) and then freeze-dried.
The expected tetrasaccharide 15 was obtained in quantitative yield (26.0
75 MHz) δ 170.0-168.7 (CO), 103.6 (d, JC, ) 230 Hz; C-1I), 99.8
F
II
(C-1II), 77.1, 74.7, 73.5, 72.6, 71.5, 70.6, 70.2, 68.3 (C-2I, II, C-3I,
,
C-4I, , C-5I, II), 60.9 (C-6I), 30.2 (C-6II), 20.8-20.4 (CH3); Η ΝΜR
II
1
(CDCl3, 300 MHz) δ 5.62 (dd, 1H, J1, 2 ) 2.7 Hz, J1, F ) 53 Hz, H-1I),
mg): [R]25 -16 (c 0.5, H2O); 13C NMR (D2O, 125 MHz) δ 137.4
D
5.42 (t, 1H, J2, ) J3,4 ) 9.8 Hz, H-3I), 5.10 (t, 1H, J2,3 ) J3,4 ) 9.8
3
(Cq arom), 129.5-129.3 (C arom), 103.82 (C-1IV), 103.47 (C-1II),
103.26 (C-1III), 101.86 (C-1I), 85.25 (C-3I), 78.98 (C-4III), 78.85 (C-
4II), 76.50 (C-5I), 75.76 (C-5III), 75.70 (C-5II), 75.12 (C-3III), 74.98 (C-
3II), 74.12 (C-2II), 73.80 (C-2I), 73.78 (C-2III), 72.3 (CH2Ph), 71.80 (C-
2IV), 69.45 (C-4IV), 69.10 (C-4I), 62.82 (C-6IV), 61.59 (C-6I), 60.89 (C-
6III), 60.74 (C-6II); ΗRFABMS calcd for C31H48O21 (M + Na)+
779.2586, found 779.2589.
Hz, H-3II), 4.89 (m, 3H, H-2I, H-2II, H-4II), 4.50 (m, 2H, H-1II, H-6Ia),
4.10 (m, 2H, H-5I, H-6Ib), 3.83 (t, 1H, J4,5 ) 9.8 Hz, H-4I), 3.63 (m,
1H, H-5II), 3.42 (dd, 1H, J5,6 ) 2.4 Hz, Ja,b) 11.5 Hz, H-6IIa), 3.26
(dd, 1H, J5,6 ) 7.3 Hz, H-6IIb), 2.10-1.93 (m,18H, CH3); FABMS:
m/z 683 [M + Na]+; Anal. Calcd for C24H32BrFO15: C,43.71; H,4.89;
Br, 12.12. Found: C, 43.87; H, 5.02; Br,. 12.13.
2,3,4-Tri-O-acetyl-6-azido-6-deoxy-â-D-glucopyranosyl-(1f4)-
2,3,6-tri-O-acetyl-r-D-glucopyranosyl fluoride (21). Compound 20
(282 mg, 0.43 mmol) was dissolved in N,N-dimethylformamide (20
mL) which contained sodium azide (298 mg, 11 equiv).The mixture
was heated at 80 °C for 12 h and then concentrated in vacuo. The
residue was dissolved in CH2Cl2, and the organic layer was washed
with H2O and dried and concentrated. Filtration through silica gel
(EtOAc-petroleum ether 1:1 v/v) gave compound 21 (235 mg, 88%)
which was crystallized in EtOH, mp 155-156 °C, [R]25D +28 (c 0.51,
CHCl3); 13C NMR (CDCl3, 75 MHz) δ 169.9-168.7 (CO), 103.5 (d,
JC,F ) 230 Hz; C-1I), 99.8 (C-1II), 74.3, 72.8, 72.5, 71.5, 70.63, 70.58,
70.4, 70.1, 69.2, 68.6 (C-2I, II, C-3I, II, C-4I, II, C-5I, II), 61.0 (C-6I), 50.8
2,3,4-Tri-O-acetyl-6-bromo-6-deoxy-â-D-glucopyranosyl-(1f4)-
2,3-di-O-acetyl-1,6-anhydro-â-D-glucopyranose (18b). To a solution
of 1,6-anhydro-â-cellobiose 18a (281 mg, 0.87 mmol) in pyridine (20
mL) at 0 °C was added triphenylphosphine (911 mg, 4 equiv) and
tetrabromomethane (578 mg, 2 equiv). After stirring the solution for
30 min at 0 °C and 2 h at 50 °C, acetic anhydride (10 mL) was added.
After an additional 3 h, the reaction mixture was worked up as described
for compound 9 and purified by flash chromatography (EtOAc-
petroleum ether 8:2 v/v) to give 18b (280 mg, 54%) which was
crystallized in MeOH, mp 140-141 °C, [R]25D -34.5 (c 0.73, CHCl3);
13C NMR (CDCl3, 75 MHz) 100δ 169.4-168.9 (CO), 0.3, 98.9 (C-1I,
II), 76.9, 73.7, 73.2, 72.7, 71.3, 70.6, 69.6, 68.5 (C-2I, II, C-3I, II, C-4I, II
,
1
(C-6II), 20.6-20.3 (CH3); Η ΝΜR (CDCl3, 300 MHz) δ 5.62 (dd,
C-5I, II), 64.9 (C-6I), 30.6 (C-6II), 20.9-20.5 (CH3); 1Η ΝΜR (CDCl3,
300 MHz) δ 5.41 (s, 1H, H-1I), 5.22-5.03 (m, 2H, H-3I, H-3II), 5.03-
4.96 (m, 2H, H-2II, H4II), 4.90 (d, 1H, J1, 2 ) 8.2 Hz, H-1II), 4.56 (m,
2H, H-2I, H-5I), 3.93 (d, 1H, Ja, b ) 7.7 Hz, H-6Ia), 3.77 (m, 2H, H-5II,
H-6Ib), 3.53 (s, 1H, H-4I), 3.44 (dd, 1H, J5, 6 ) 2.7 Hz, Ja, b ) 11.5 Hz,
H-6IIa), 3.33 (dd, 1H, J5, 6 ) 6.6 Hz, H-6IIb), 2.12-1.96 (m, 15H, CH3);
DCIMS: m/z 616 [M + H + NH3]+; Anal. Calcd for C22H29BrO14:
C,44.23; H,4.89; Br, 13.38. Found: C, 43.95; H, 5.10; Br,. 13.26.
1H, J1,2 ) 2.4 Hz, J1,F ) 53 Hz, H-1I), 5.44 (t, 1H, J2,3 ) J3,4 ) 9.8
Hz, H-3I), 5.13 (t, 1H, J2,3 ) J3,4 ) 9.3 Hz, H-3II), 4.95-4.80 (m, 3H,
H-2I, H-2II, H-4II), 4.57-4.50 (m, 2H, H-1II, H-6Ia), 4.10 (m, 2H, H-5I,
H-6Ib), 3.87 (t, 1H, J4,5 ) 9.3 Hz, H-4I), 3.60 (m, 1H, H-5II), 3.33 (m,
2H, H6IIa, H-6IIb), 2.10-1.95 (m,18H, CH3); DCIMS: m/z 639 [M +
H + NH3]+; Anal. Calcd for C24H32FN3O15: C,46.38; H,5.19; F, 3.06,
N, 6.76. Found: C, 46.67; H, 5.37; F, 2.87; N, 6.59.